RIM
PETX

RS Investment Management’s Aratana Therapeutics, Inc. PETX Stock Holding History

RS Investment Management’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-568,804
Closed -$8.88M – 407
2014
Q2 		$8.88M Sell
568,804
-10,096
-2% -$143K 0.07% 239
2014
Q1 		$10.7M Buy
+578,900
New +$11.6M 0.06% 227

Other funds holding PETX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

RS Investment Management's PETX Position: Q3 2014 in Review

RS Investment Management sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2014, closing a stake of 568,804 shares — an estimated $8.88M sold.

RS Investment Management first reported a position in PETX in Q1 2014 and held it in 2 quarters. The position peaked at $10.7M in Q1 2014. 82 funds tracked by Wall St. Rank hold PETX as of Q3 2014.

  • RS Investment Management reported no remaining Aratana Therapeutics, Inc. position as of Q3 2014 after selling out during the quarter.
  • RS Investment Management sold 568,804 Aratana Therapeutics, Inc. shares in Q3 2014, an estimated $8.88M.
  • RS Investment Management first reported a position in Aratana Therapeutics, Inc. in Q1 2014 and held it in 2 quarters.
  • RS Investment Management's Aratana Therapeutics, Inc. position peaked at $10.7M in Q1 2014.
  • 82 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2014.

Based on RS Investment Management's 13F filing for Q3 2014, filed 14 Nov 2014.